➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Johnson and Johnson
Express Scripts
Dow
Moodys

Last Updated: January 27, 2021

DrugPatentWatch Database Preview

Litigation Details for Alcon Research, Ltd. v. Watson Laboratories, Inc. (D. Del. 2016)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Alcon Research, Ltd. v. Watson Laboratories, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Alcon Research, Ltd. v. Watson Laboratories, Inc. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2017-11-09 147 constructions for disputed terms in U.S. Patent Nos. 7,947,295 and 8,'921,337; WHEREAS, on …#39;295 patent col. 3 11. 26-33. The Court is not persuaded that, in the context of the patent as a whole…(See D.I. 58 at 7-12) Watson contends that the patent contains a clear disavowal of claim scope, making…embodiments." (D.I. 58 at 11) (quoting '295 patent col. 3 11. 26-33) In particular, Watson relies …amounts to a clear and unmistakable disavowal. The patent goes on to 1 This term appears External link to document
2018-04-17 177 for disputed terms in U.S. Patent No. 9,662,398 ("'398 patent"); WHEREAS, on December…found, the patent does not explicitly define "native guar," nor does the patent define a "…the ' 398 patent at col. 411. 1-7. The specification states that the patent "relates …Feb. 5, 2010. '398 patent, col. 411. 24-30 (emphasis added). Thus, the patent refers to a commercial…nepafenac, citing to two patents, which are fully incorporated by reference. '398 patent, col. 4 11. 49-52 External link to document
2016-03-04 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,947,295 B2; 8,921,337 B2. (…4 March 2016 1:16-cv-00129-LPS-SRF Patent None District Court, D. Delaware External link to document
2017-02-15 58 infringement of United States Patent Nos. 7,947,295 ("the '295 patent") and 8,921,337 ("…quot;the '337 patent") (the "asserted patents" or the "patents-in-suit").…Asserted Patents 1. The '295 Patent The '295 patent is entitled…was issued on May 24, 2011. ('295 patent) The '295 patent claims pharmaceutical compositions… increase in viscosity. ('295 patent, abstract) The patent's specification explains that the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Mallinckrodt
McKesson
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.